ShangPharma Corporation Issues Statement in Response to Name Confusion
ShangPharma Corporation (NYSE: SHP) today issued a statement to clarify potential market confusion between the name of the Company and Shanghai Pharmaceuticals Holdings Co., Ltd. (2607.HK, 601607.SH).
"To clarify any confusion in the market, ShangPharma has no affiliation with Shanghai Pharmaceuticals Holdings Co., Ltd.," the Company stated. "While the names are similar in English, the Chinese character 'Shang' in ShangPharma is different than the character in 'Shanghai Pharmaceuticals Holdings Co., Ltd. '"
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.